These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 26760158)

  • 21. Bias in Markov models of disease.
    Faissol DM; Griffin PM; Swann JL
    Math Biosci; 2009 Aug; 220(2):143-56. PubMed ID: 19538974
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Family pediatrics: report of the Task Force on the Family.
    Schor EL;
    Pediatrics; 2003 Jun; 111(6 Pt 2):1541-71. PubMed ID: 12777595
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Systematic assessment of decision-analytic models for chronic myeloid leukemia.
    Rochau U; Schwarzer R; Jahn B; Sroczynski G; Kluibenschaedl M; Wolf D; Radich J; Brixner D; Gastl G; Siebert U
    Appl Health Econ Health Policy; 2014 Apr; 12(2):103-15. PubMed ID: 24385259
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficient representation and P-value computation for high-order Markov motifs.
    da Fonseca PG; Guimarães KS; Sagot MF
    Bioinformatics; 2008 Aug; 24(16):i160-6. PubMed ID: 18689819
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Health economic evaluation: important principles and methodology.
    Rudmik L; Drummond M
    Laryngoscope; 2013 Jun; 123(6):1341-7. PubMed ID: 23483522
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Health-related quality of life, satisfaction, and economic outcome measures in studies of prostate cancer screening and treatment, 1990-2000.
    McNaughton-Collins M; Walker-Corkery E; Barry MJ
    J Natl Cancer Inst Monogr; 2004; (33):78-101. PubMed ID: 15504921
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Alternative decision analysis modeling in the economic evaluation of tumor necrosis factor inhibitors for rheumatoid arthritis.
    Kamal KM; Miller LA; Kavookjian J; Madhavan S
    Semin Arthritis Rheum; 2006 Aug; 36(1):50-60. PubMed ID: 16887468
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Determining the impact of modeling additional sources of uncertainty in value-of-information analysis.
    Ramos IC; P M H M; Mölken RV; Al MJ
    Value Health; 2015 Jan; 18(1):100-9. PubMed ID: 25595240
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expected value of perfect information: an empirical example of reducing decision uncertainty by conducting additional research.
    Oostenbrink JB; Al MJ; Oppe M; Rutten-van Mölken MP
    Value Health; 2008 Dec; 11(7):1070-80. PubMed ID: 19602213
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Insights and networks: methodological assessment and scientometric analysis of economic evaluations in dentistry.
    Naved N; Lal A; Umer F
    BMC Health Serv Res; 2024 Oct; 24(1):1182. PubMed ID: 39367462
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cost-effectiveness analysis of molecular testing in minimally invasive samples to detect endometrial cancer in women with postmenopausal bleeding.
    Peremiquel-Trillas P; Gómez D; Martínez JM; Fernández-González S; Frias-Gomez J; Paytubi S; Pelegrina B; Pineda M; Brunet J; Ponce J; Matias-Guiu X; Bosch X; de Sanjosé S; Bruni L; Alemany L; Costas L; Díaz M
    Br J Cancer; 2023 Aug; 129(2):325-334. PubMed ID: 37165201
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A review of simulation models for the long-term management of type 2 diabetes in low-and-middle income countries.
    Mukonda E; Cleary S; Lesosky M
    BMC Health Serv Res; 2021 Dec; 21(1):1313. PubMed ID: 34872555
    [TBL] [Abstract][Full Text] [Related]  

  • 33. On the Use of Markov Models in Pharmacoeconomics: Pros and Cons and Implications for Policy Makers.
    Carta A; Conversano C
    Front Public Health; 2020; 8():569500. PubMed ID: 33194969
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cost-Effectiveness of Rheumatic Heart Disease Echocardiographic Screening in Brazil: Data from the PROVAR+ Study: Cost-effectiveness of RHD screening in Brazil.
    Ubels J; Sable C; Beaton AZ; Nunes MCP; Oliveira KKB; Rabelo LC; Teixeira IM; Ruiz GZL; Rabelo LMM; Tompsett AR; Ribeiro ALP; Sahlen KG; Nascimento BR;
    Glob Heart; 2020 Feb; 15(1):18. PubMed ID: 32489791
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Application of Multi-State Model in Analyzing of Breast Cancer Data.
    Vasheghani Farahani M; Ataee Dizaji P; Rashidi H; Mokarian F; Biglarian A
    J Res Health Sci; 2020 Jan; 19(4):e00465. PubMed ID: 32291364
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An event driven hybrid identity management approach to privacy enhanced e-health.
    Sánchez-Guerrero R; Almenárez F; Díaz-Sánchez D; Marín A; Arias P; Sanvido F
    Sensors (Basel); 2012; 12(5):6129-54. PubMed ID: 22778634
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Markov Models in health care.
    Sato RC; Zouain DM
    Einstein (Sao Paulo); 2010 Sep; 8(3):376-9. PubMed ID: 26760158
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Markov models in medical decision making: a practical guide.
    Sonnenberg FA; Beck JR
    Med Decis Making; 1993; 13(4):322-38. PubMed ID: 8246705
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A mathematical approach for evaluating Markov models in continuous time without discrete-event simulation.
    van Rosmalen J; Toy M; O'Mahony JF
    Med Decis Making; 2013 Aug; 33(6):767-79. PubMed ID: 23715464
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.